Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Euro Antibiotics 2021

About conference

We welcome all the participants from everywhere the world to attend Euro Antibiotics 2021 to be persisted on February 26-27, 2021 Webinar, which incorporates prompt keynote presentations, Oral talks, Poster presentations.
 
Conference Series LLC Ltd is organizing 2nd Annual Congress on Antibiotics and Bacterial Infections webinar on February 26-27 2021. We organize Antimicrobial Meetings within the fields associated with Antibacterial Studies and Research.
 
The use of antibiotics having a crucial concern for selection of resistance, not completely among pathogenic bacteria also among the commensal ones. publicly health antimicrobial resistance may be a major problem thanks to possibility in therapeutic failure. the first objective of this meeting is to compile researchers involved in antibiotic and Bacterial Infections  prevention and control. The meeting will take a unified approach to research and it'll cause researchers specializing in several subjects associated with antibiotics and Bacterial Infections. We expected to present a universal vision of the importance of antimicrobial and Bacterial Infections in several ecosystems and what are often done about it.
 
 

Why to attend

Why to attend?
EURO ANTIBIOTICS 2021 may be a platform to debate and study the newest advancements within the field of Antibiotics because the world's consideration turned regarding the urgency of latest antibiotics because the antimicrobial resistance and Bacterial Infections is growing day by day. Many developed nations and International health organizations try to focus of the present situation and making new policies to stop the adverse effects of Bacterial Infections.
 
The 2-day webinar gathers researchers, academia, labs, Drug Manufacturers, government agencies, health professionals, hospitals, young investigators, pharma and labs and presents their opinions through key notes, and case study presentations. This conference lays a platform for all the researchers working within the field of Antibiotics to understand the newest developments and therefore the current situation of the Antibiotic & Bacterial Infections
Who will attend and Who you'll meet
2nd Annual Congress on Antibiotics and Bacterial Infections is exclusively designed for:
 
Researchers
Academia
Drug Manufacturers
Government agencies
Healthcare professionals
Hospitals/ Clinics
Methodologists
Young investigators
Medical Directors
Principal Investigators
Clinical Research organizations
Senior executives of Biotech, Biomedical, Medical devices and Pharmaceutical industries.
 
This conference lays a platform for all the researchers working within the field of microbiology/antibiotics to understand the newest developments and therefore the current situation of the Antibiotics and Bacterial Infections problem. We welcome all the participants from everywhere the planet to attend 2nd Annual Congress on Antibiotics and Bacterial Infections to be persisted February 26-27, 2021 (Webinar) which incorporates prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
 

Session & Tracks

Track 1: Antibiotics

Antibiotics are a kind of antimicrobials that are utilized in treatment and prevention of bacterial infections. they'll kill or inhibit the expansion of bacteria. Many antibiotics also are effective against protozoans and fungi; some are toxic to humans and animals also, even when given in therapeutic dosage. Antibiotics aren't effective against viruses like cold or influenza, and should be harmful when taken inappropriately. Physicians must make sure the patient features a bacterial infection before prescribing antibiotics.

 

Track 2: Antibiotics in several Industries

Antibiotics must be used accordingly in humans and animals because both uses share to the emergence, persistence, and escalation of resistant bacteria. Bacteria in food-producing animals are of particular concern. Food animals play as a source of resistant pathogens and resistance mechanisms which will directly or indirectly end in antimicrobial  infections in humans. Bacteria could also be transmitted to humans through the foods we eat. Some bacteria have turned immune to quite one kind of antibiotic, which makes it harder to treat the infections they cause. Sustaining the efficiency of antibiotic drugs is significant to insulating human and animal health.

 

Track 3: Clinical Trials of Antibiotics

Prescribing doctors are, progressively, using clinical trial data as a major source of information for evidence-based medicine for the remedy of infectious diseases, as in other clinical disciplines. However, it may be difficult to excerpt from these data the material that is needed for the management of the individual patient. At the same time, clinical trial testimony have been used, probably satisfactorily, in the process of drug registration, and the pharmaceutical industry has spent progressively large amount of money to satisfy the needs of this process. In the face of all these problems, switch in the way antibiotic clinical trials are designed and performed are clearly necessary, although this must not disturb the balance so far as to restore them less useful for those who currently derive greatest benefit from them.

 

Track 4: Subsequent Generation Approach of Antibiotics

The discovery of a replacement of antibiotic is called  teixobactin was announced by international team of researchers, in January this year. it's the foremost significant new antibiotic to be discovered in additional than 30 years, and it's going to help combat the growing number of drug-resistant bacteria.

 

Track 5: Alternative to Antibiotics

This  method uses the enzymes of bacteriophages to attack the bacteria. Bacteriophages are tiny viruses that infect bacteria. After they infect the bacteria, they replicate or make copies of themselves, then leave the bacteria to travel and infect other bacteria. To be ready to leave the bacteria, the "phages" make an enzyme that dissolves the wall of the bacterial cell, thus killing it.

 

Track 6: Origins and kinds of Antibiotic and Antimicrobials

The world is within the midst of an emerging crisis of antibiotic resistance to microbial pathogens. Numerous pathogens that became immune to commonly used antibiotics are described in various contexts, including drug-resistant methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus pneumonia, and tubercle bacillus . Considering the breadth of effect and significant impact on morbidity and mortality, multi-drug-resistant (MDR) pathogens are a considerable threat to public health. Although this problem involves the event of latest antibiotics with new mechanisms of action, the pharmaceutical industry has abandoned the world as less lucrative for his or her investments. the amount of latest antibiotics approved by the U.S. Food and Drug Administration (FDA) declined dramatically during the past 2 decades.

 

Track 7: Genetics and Proteomics of antimicrobial

Bacteria can acquire antimicrobial genes from other bacteria in several ways. By undergoing an easy mating process called "conjugation," bacteria can transfer genetic material, including genes encoding resistance to antibiotics (found on plasmids and transposons) from one bacterium to a different . Antibiotic resistance genes are identified in diverse environments including soil, gull feces and, increasingly, within the human gut microbiota. Scientists have applied a variety of approaches to detect antimicrobial genes in environmental or non-clinical microbiomes, all of which have their own inherent strengths/limitations.

Proteomic studies have improved our understanding of the microbial world. the foremost recent advances during this field have helped us to explore aspects beyond genomics. Proteomics has also advanced our knowledge of mechanisms of bacterial virulence and a few important aspects of how bacteria interact with human cells and, thus, of the pathogenesis of infectious diseases. we've used proteomic technology to elucidate the complex cellular responses of Bacillus subtilis to antimicrobial compounds belonging to classical and emerging antibiotic classes.

 

Track 8: Antimicrobial : Public Health Concerns

This topic reviews the worldwide antibiotic markets, including discussions on the market development and growth potential over subsequent 5 years. It also analyses key factors that are driving the market growth. It describes the trends intimately with reference to various antibiotic classes, including the novel classes that are emerging and their technological basis. It includes in-depth discussions of the industry structure and therefore the regulatory environment. it's valuable reading for investors, policymakers, and industry participants. Profiles of leading players within the industry also are included.

 

Such involved analyses are conducted to assist strategy developers and decision makers within pharmaceutical companies and government bodies. The detailed analyses of the regulatory factors that play major roles choose the industry trends are especially useful for legislators involved in government policy development programs. Technology trend and patent analyses give an summary of the new trends with reference to innovation within the world .

 

Track 9: Antibiotic surveillance and safety concerns

In the time since penicillin was discovered nearly 80 years ago, antibiotics became one among the foremost important lifesaving weapons in doctors' arsenal against bacterial infection. Now, the Lakeland, Fla.-based Publix grocery chain is making a gift of seven of those drugs freed from charge to those that have prescriptions for them. Five of those are amoxicillin, ampicillin, cephalexin, erythromycin and penicillin VK -- are commonly employed by doctors to treat bacterial infections starting from ear infections to gonorrhea. But two of the drugs on the list -- ciprofloxacin and sulfamethoxazole/trimethoprim -- are high-grade antibiotics that doctors usually reserve for particularly serious infections.

 

While some hail the program as a godsend, others fear that the move could lead on to overuse of the drugs.

 

This is because the utilization of antibiotics comes attached with important considerations. consistent with the American Academy of Family Physicians, there are certain situations during which antibiotics are helpful -- and lots of during which they will cause more harm than good.

 

Penicillins, Cephalosporins, Aminoglycosides, Glycopeptides, Tetracyclines are antibiotics most ordinarily showing side effects.

 

Track 10: Analytical strategies for Antimicrobials & Antibiotics

The analysis of antibiotic susceptibility disks by high-pressure liquid chromatography (HPLC) methods are presented for the potency determination of mecillinam, ampicillin, carbenicillin, and cephalotjiin alone and in various combinations. Good agreement between HPLC and microbiological data is observed for potency determinations with recoveries of greater than 95%. Relative standard deviations of less than 2% are recorded for every HPLC method. HPLC methods offer improved accuracy and greater precision in comparison to the quality microbiological methods of study for susceptibility disks. the foremost popular analytical methods for the determination of beta-lactams are the chromatographic ones, including high performance liquid-chromatography (HPLC) and thin layer chromatography (TLC).

 

HPLC offers high sensitivity and separation efficiency, establishing itself because the first choice method for the analysis of beta-lactams; however it's expensive and requires sophisticated equipment. TLC may be a less costly and fewer complicated chromatographic procedure, which may be successfully used, within the preliminary screening of pharmaceutical substances. In modern analysis, TLC is typically used as a separation method, which establishes the presence or absence of beta-lactam antibiotics above an outlined level of concentration.

 

Track 11: Role of future antibiotics & antimicrobial in diseases

Antibiotics are applied for the treatment of autoimmune diseases for over five decades, supported the premise that infections play a task within the initiation and propagation of those entities. The antibiotics market was valued at USD 39.8 million in 2015 and is predicted to witness a CAGR of 4.0% over the forecast period. Increasing efforts are being witnessed toward the event of advanced products. consistent with the info published by the Pew public trust , in March 2016, about 37 promising molecules were being investigated within the U.S. market. Majority of those , are in phase II clinical trial clinical trials and are anticipated to hit the market between 2018 - 2020. Furthermore, supportive government legislations, like the Generating Antibiotics Incentives Now (GAIN) Act are expected to expedite the approval process. GAIN Act has provisions which facilitate development of therapy against antibiotic resistant pathogens.

 

Track 12: Infectious Diseases

This term is one among the weightage issues within the recent times. As discussed earlier, many new sorts of strains are coming into existence which creates infections even deadlier infections which is so called Infectious Diseases. Researchers of this sort , Infectious Diseases specialists are paid high and that they are considered to be a top niche says the study. does one agree and have you ever found any new strains, then submit your research article to our review committees today.

 

Track-13: Bacteriology

Bacteria are single cellular microorganisms that lack a nuclear membrane and are dividing by binary fission. The study of bacteria called as bacteriology. Bacteriological study helps within the field of agricultural, or soil, bacteriology; clinical diagnostic bacteriology; industrial bacteriology; marine bacteriology; public-health bacteriology; sanitary, or hygienic, bacteriology; and systematic bacteriology. Major researches during this field help in development of the many useful vaccines. the main advantages are the invention of antibiotics that are helpful within the diagnosis of varied sorts of disease. Recombinant bacteria are useful in bacteriologic research to manufacture biomolecules (e.g. interferon) needed for research and patient care.

 

Track-14: Human Bacteriology

It is the study about the bacterial diseases, their causal agents, morphology, and diagnostics method in human. the foremost common human bacterial diseases are Pneumonia, Cholera, Influenza, Tuberculosis, Measles, Typhoid, Malaria, Anthrax. Mostly recently discovered viruses are valley Virus, Oropouche, Mayaro. The Symptoms of Genus leptospirosis is high fever, headache, chills, and vomiting, and should include jaundice, red eyes, abdominal pain, diarrhea. Some exotic diseases are zoonotic which may pass between animals and humans, like rabies.

 

Track-15: Plant Bacteriology

Plant bacteriology is a study that involves of bacteria identification, disease etiology, disease cycles, economic impact, epidemiology of plant diseases, disease resistance, the way during which plant diseases affect humans and animals. Some bacteria causes a little proportion of plant diseases, this doesn't mean that these diseases are unimportant. Pathogenic tests are often finished the prevention of disease. Both natural and cultivated plants carry genetics disease resistance, but there are numerous samples of devastating disease .

 

Track 16: Healthcare-associated Infection .

Healthcare-associated Infection (HAIs) is infections that patients get while receiving treatment for medical or surgical conditions, and lots of HAIs are preventable. Modern healthcare employs many sorts of invasive devices and procedures to treat patients and to assist them recover. Infections are often related to procedures (like surgery) and also the devices utilized in medical procedures, like catheters or ventilators. HAIs are important causes of morbidity and mortality within the us and are related to a considerable increase in health care costs annually . At anybody time within the us , 1 out of each 25 hospitalized patients are suffering from an HAI.

 

To Collaborate Scientific Professionals around the World

Conference Date February 26-27, 2021

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by